DrugPatentWatch Database Preview
Details for Biologics License Application: 103196
» See Plans and Pricing
Summary for BLA: 103196
| Tradename: | THROMBATE III |
| Applicant: | Grifols Usa, Llc |
| Ingredient: | antithrombin iii (human) |
| Patents: | 5 |
| Approval Date: | Dec 30, 1991 |
| Suppliers: see list | 1 |
US Patents for BLA: 103196
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grifols Usa, Llc | THROMBATE III | antithrombin iii (human) | KIT | 103196 | 1 | 1991-12-30 | Start Trial | 2008-07-25 | search | |||
| Grifols Usa, Llc | THROMBATE III | antithrombin iii (human) | KIT | 103196 | 1 | 1991-12-30 | Start Trial | Genzyme Transgenic Corporation (Framingham, MA) | 2040-01-28 | search | ||
| Grifols Usa, Llc | THROMBATE III | antithrombin iii (human) | KIT | 103196 | 1 | 1991-12-30 | Start Trial | Biovitrum AB (Stockholm, SE) | 2014-06-23 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
